Viewing StudyNCT00142181



Ignite Creation Date: 2024-05-05 @ 11:50 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00142181
Status: COMPLETED
Last Update Posted: 2012-12-21
First Post: 2005-09-01

Brief Title: Phase II Study of Campath-1H Antibody to Treat Waldenstroms Macroglobulinemia
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-03
Start Date Type: None
Primary Completion Date: 2005-10
Primary Completion Date Type: ACTUAL
Completion Date: 2008-06
Completion Date Type: ACTUAL
First Submit Date: 2005-09-01
First Submit QC Date: September 1 2005
Study First Post Date: 2005-09-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2012-12-19
Last Update Post Date: 2012-12-21
Last Update Post Date Type: ESTIMATED